To review uterine embolization (UE) technique.
To describe our protocol for diagnosis,
treatment and follow-up of uterine fibroids.
To review the imaging and clinical changes in Magnetic Resonance Images (MRI) in a series of 21 cases.
Uterine fibroids are the most frequent gynecological tumors that appear in women of reproductive age.
They are benign monoclonal tumors that arise from smooth muscle cells of the myometrium.
They are usually asymptomatic and diagnosed incidentally.
When they are symptomatic they often require treatment that include hormonal,
surgical treatment or embolization.
UE is a minimally invasive procedure for treatment of symptomatic uterine fibroids.
MRI is the best imaging technique for diagnosis,
evaluation and post-treatment radiological follow-up.
size and location of fibroids must be...
Findings and procedure details
Our purpose is to review the embolization technique as well as the MR images in a series of 21 cases.
Symptomatic uterine fibroids are the main indication for uterine embolization.
The most common clinical syndromes are hypermenorrhea,
dyspareunia or abdominal pain.
Before the procedure a complete gynecological and imaging evaluation is necessary to rule out contraindications.
endometrial and uterine pathology need to beexcludedbefore the procedure as well as the location of fibroids.
Literature recommends avoiding this technique in pedunculated fibroids.
Uterine embolization technique in...
Uterine fibroids are the most frequent pelvic tumors in women.
When they are symptomatic they often require treatment.
EU is a safe and useful procedure for the treatment of symptomatic fibroids with an efficacy of 95% in our series.
MRI is the best imaging technique for pre-treatment evaluation and after uterine embolization.
Role of MR imaging of uterine leiomyomas before and after embolization.
Current concepts in uterine fibroid embolization.
Uterine fibroid vascularization and clinical relevance to uterine fibroid embolization.
Lancet 2001;357 (9252):293–298.
Management of uterine fibroids: an update of the evidence.
Evidence report/technology assessment no.